Acetylator phenotype in patients with lung carcinoma ― a negative reportBURGESS, E. J; TRAFFORD, J. A. P.European journal of respiratory diseases. 1985, Vol 67, Num 1, pp 17-19, issn 0106-4339Article

Acetylation phenotype in colorectal carcinomaILETT, K. F; DAVID, B. M; DETCHON, P et al.Cancer research (Baltimore). 1987, Vol 47, Num 5, pp 1466-1469, issn 0008-5472Article

Acetylator phenotypes: effect of ageGACHALYI, B; VAS, A; HAJOS, P et al.European journal of clinical pharmacology. 1984, Vol 26, Num 1, pp 43-45, issn 0031-6970Article

Répartition du phénotype acétylateur parmi des sujets normaux et alcooliques dans la population urbaine de MoscouLIL'IN, E. T; KORSUNSKAYA, M. P; MEKSIN, V. A et al.Genetika. 1984, Vol 20, Num 9, pp 1557-1559, issn 0016-6758Article

Ageing and acetylator phenotype as determined by administration of sulphadimidinePONTIROLI, A. E; DE PASQUA, A; BONISOLLI, L et al.European journal of clinical pharmacology. 1985, Vol 28, Num 4, pp 485-486, issn 0031-6970Article

Conséquences cliniques du polymorphisme génétique de la N-acetylation = Clinical significance of N-acétylation genetic polymorphismPRALONG, E; GASCON, M.-P; DAYER, P et al.Médecine et hygiène. 1986, Vol 44, Num 1653, pp 1162-1170, issn 0025-6749Article

Puissance d'acétylation de l'isoniazide et pigmentation dans la population blanche: incidences pratiques et perspectives embryologiques = Power of isoniazid's acetylation and pigmentation in white people. Useful incidences and embryological perspectivesLEPERCHEY, F; VIVIEN, J. N; VICAUT, E et al.Thérapie (Paris). 1983, Vol 38, Num 6, pp 613-620, issn 0040-5957Article

Acetylation phenotype in abstinent alcoholicsGUTHRIE, S. K; LANE, E. A; LINNOILA, M et al.Alcoholism, clinical and experimental research. 1989, Vol 13, Num 1, pp 66-68, issn 0145-6008Article

Inactivation de l'isoniazide chez l'enfant = Isoniazid inactivation in childrenPAIRE, M; LAVARENNE, J; RODET, M. F et al.Thérapie (Paris). 1984, Vol 39, Num 6, pp 625-631, issn 0040-5957Article

Evolutionarily conserved non-AUG translation initiation in NAT1/p97/DAP5 (EIF4G2)TAKAHASHI, Kazutoshi; MAMYAMA, Masayoshi; TOKUZAWA, Yoshimi et al.Genomics (San Diego, Calif.). 2005, Vol 85, Num 3, pp 360-371, issn 0888-7543, 12 p.Article

Biochemical investigation of the basis for the genetic N-acetylation polymorphism in the inbred hamsterHEIN, D. W; KIRLIN, W. G; FERGUSON, R. J et al.The Journal of pharmacology and experimental therapeutics. 1985, Vol 234, Num 2, pp 358-374, issn 0022-3565Article

Survey of the human acetylator polymorphism in spontaneous disordersEVANS, D. A. P.Journal of medical genetics. 1984, Vol 21, Num 4, pp 243-253, issn 0022-2593Article

A web server for inferring the human N-acetyltransferase-2 (NAT2) enzymatic phenotype from NAT2 genotypeKUZNETSOV, Igor B; MCDUFFIE, Michael; MOSLEHI, Roxana et al.Bioinformatics (Oxford. Print). 2009, Vol 25, Num 9, pp 1185-1186, issn 1367-4803, 2 p.Article

A simple test for acetylator phenotype using caffeine. Commentary. Authors' replyGRANT, D. M; TANG, B. K; KALOW, W et al.British journal of clinical pharmacology. 2004, Vol 58, Num 7, pp S788-S795, issn 0306-5251Article

A competitive enzyme linked immunosorbent assay for the determination of N-acetyltransferase (NAT2) phenotypesWONG, P; LEYLAND-JONES, B; WAINER, I. W et al.Journal of pharmaceutical and biomedical analysis. 1995, Vol 13, Num 9, pp 1079-1086, issn 0731-7085Article

The lack of relationship between acetylator phenotype and idiopathic systemic lupus erythematosus in a south-east Asian population : a study of Indians, Malays and Malaysian ChineseMEI LIN ONG; MANT, T. G. K; VEERAPEN, K et al.British journal of rheumatology. 1990, Vol 29, Num 6, pp 462-464, issn 0263-7103Article

Polymorphic N-acetylation capacity in lung cancerPHILIP, P. A; FITZGERALD, D. L; CARTWRIGHT, R. A et al.Carcinogenesis (New York. Print). 1988, Vol 9, Num 3, pp 491-493, issn 0143-3334Article

Further evidence for the lack of association between acetylator phenotype and systemic lupus erythematosusBAER, A. N; WOOSLEY, R. L; PINCUS, T et al.Arthritis and rheumatism. 1986, Vol 29, Num 4, pp 508-514, issn 0004-3591Article

Significance of acetylator phenotype in pharmacokinetics and adverse effects of procainamideYLITALO, P; RUOSTEENOJA, R; LESKINEN, O et al.European journal of clinical pharmacology. 1983, Vol 25, Num 6, pp 791-795, issn 0031-6970Article

N-acetylation pharmacogenetics: Michaelis-Menten constants for arylamine drugs as predictors of their N-acetylation rates in vivoANDRES, H. H; WEBER, W. W.Drug metabolism and disposition. 1986, Vol 14, Num 4, pp 382-385, issn 0090-9556Article

New directions in pharmacogeneticsVESELL, E. S.Federation proceedings. 1984, Vol 43, Num 8, pp 2319-2347, issn 0014-9446Article

Acetylator phenotyping with sulphadimidine in patients receiving isoniazidYLITALO, P; AUTERINEN, L; MARTTINEN, A et al.International journal of clinical pharmacology research. 1984, Vol 4, Num 2, pp 141-144, issn 0251-1649Article

Acetylation of maprotiline and desmethylmaprotiline in depressive patients phenotyped with sulfamidine, debrisoquine, and mephenytoinBAUMANN, P; BOSSHART, P; GABRIS, G et al.Arzneimittel-Forschung. 1988, Vol 38, Num 2, pp 292-296, issn 0004-4172Article

High incidence of the slow nitrazepam acetylator phenotype in a Nigerian populationEZE(L. C.).Biochemical genetics. 1987, Vol 25, Num 3-4, pp 225-229, issn 0006-2928Article

Elevated serum aminotransferase induced by isoniazid in relation to isoniazid acetylator phenotypeYAMAMOTO, T; SUOU, T; HIRAYAMA, C et al.Hepatology (Baltimore, Md.). 1986, Vol 6, Num 2, pp 295-298, issn 0270-9139Article